NDatalyze Financial Statements From 2010 to 2025
| NDATF Stock | USD 0.01 0.00 0.00% |
Check NDatalyze Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NDatalyze Corp's main balance sheet or income statement drivers, such as , as well as many indicators such as . NDatalyze financial statements analysis is a perfect complement when working with NDatalyze Corp Valuation or Volatility modules.
NDatalyze |
nDatalyze Corp OTC Stock Return On Equity Analysis
NDatalyze Corp's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current NDatalyze Corp Return On Equity | -1.0 |
Most of NDatalyze Corp's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, nDatalyze Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, nDatalyze Corp has a Return On Equity of -0.9976. This is 95.84% lower than that of the Healthcare sector and significantly lower than that of the Health Information Services industry. The return on equity for all United States stocks is notably higher than that of the company.
nDatalyze Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NDatalyze Corp's current stock value. Our valuation model uses many indicators to compare NDatalyze Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NDatalyze Corp competition to find correlations between indicators driving NDatalyze Corp's intrinsic value. More Info.nDatalyze Corp is considered to be number one stock in return on equity category among its peers. It is regarded second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NDatalyze Corp's earnings, one of the primary drivers of an investment's value.About NDatalyze Corp Financial Statements
NDatalyze Corp stakeholders use historical fundamental indicators, such as NDatalyze Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Although NDatalyze Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in NDatalyze Corp's assets and liabilities are reflected in the revenues and expenses on NDatalyze Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in nDatalyze Corp. Please read more on our technical analysis and fundamental analysis pages.
nDatalyze Corp. generates technology-based health-related solutions. The company was formerly known as MedXtractor Corp. and changed its name to nDatalyze Corp. in October 2021. nDatalyze Corp. was incorporated in 2018 and is headquartered in Calgary, Canada. Ndatalyze Corp is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in NDatalyze OTC Stock
NDatalyze Corp financial ratios help investors to determine whether NDatalyze OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NDatalyze with respect to the benefits of owning NDatalyze Corp security.